Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice

Cell Host and Microbe

Volumn 17, Issue 4, 2015, Pages 526-535

  Mikolajczak, Sebastian A ^a   Vaughan, Ashley M ^a   Kangwanrangsan, Niwat ^b   Roobsoong, Wanlapa ^c   Fishbaugher, Matthew ^a   Yimamnuaychok, Narathatai ^c   Rezakhani, Nastaran ^a   Lakshmanan, Viswanathan ^a   Singh, Naresh ^d   Kaushansky, Alexis ^a   Camargo, Nelly ^a   Baldwin, Michael ^a   Lindner, Scott E ^f   Adams, John H ^d   Sattabongkot, Jetsumon ^c   Kappe, Stefan H I ^a,e  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b Mahidol University   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL CARRIER PROTEIN; ATOVAQUONE; CHAPERONIN 60; MACROPHAGE MIGRATION INHIBITION FACTOR; PRIMAQUINE; ANTIMALARIAL AGENT;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICOMPLEXAN LIFE CYCLE STAGE; ARTICLE; CELL INVASION; CHIMERA; CONTROLLED STUDY; DNA REPLICATION; FEMALE; HEPATITIS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HYPNOZOITE; IN VIVO STUDY; LIVER; MEROZOITE; MITOCHONDRION; MOUSE; NONHUMAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RETICULOCYTE; SPOROZOITE; ANIMAL; CHEMOPROPHYLAXIS; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; MALARIA, VIVAX; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SCID MOUSE; TREATMENT OUTCOME;

ANIMALIA; MUS; PLASMODIUM VIVAX;

ANIMALS; ANTIMALARIALS; CHEMOPREVENTION; CHIMERA; DISEASE MODELS, ANIMAL; HUMANS; LIVER; MALARIA, VIVAX; MICE, KNOCKOUT; MICE, SCID; PLASMODIUM VIVAX; PRIMAQUINE; TREATMENT OUTCOME;

EID: 84927018652     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2015.02.011     Document Type: Article

References (41)

1. N.M. Anstey, N.M. Douglas, J.R. Poespoprodjo, and R.N. Price Plasmodium vivax: clinical spectrum, risk factors and pathogenesis Adv. Parasitol. 80 2012 151 201
2. H. Azuma, N. Paulk, A. Ranade, C. Dorrell, M. Al-Dhalimy, E. Ellis, S. Strom, M.A. Kay, M. Finegold, and M. Grompe Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice Nat. Biotechnol. 25 2007 903 910
3. K.D. Bissig, T.T. Le, N.B. Woods, and I.M. Verma Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model Proc. Natl. Acad. Sci. USA 104 2007 20507 20511
4. J.M. Carlton, B.J. Sina, and J.H. Adams Why is Plasmodium vivax a neglected tropical disease? PLoS Negl. Trop. Dis. 5 2011 e1160
5. W.E. Collins, P.G. Contacos, J.R. Jumper, C.S. Smith, and J.C. Skinner Studies on human malaria in aotus monkeys. 3. Exoerythrocytic stages of the Salvador II strain of Plasmodium vivax J. Parasitol. 59 1973 859 866
6. L. Dembélé, J.F. Franetich, A. Lorthiois, A. Gego, A.M. Zeeman, C.H. Kocken, R. Le Grand, N. Dereuddre-Bosquet, G.J. van Gemert, and R. Sauerwein Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures Nat. Med. 20 2014 307 312
7. D.L. Doolan, R.C. Hedstrom, W.O. Rogers, Y. Charoenvit, M. Rogers, P. de la Vega, and S.L. Hoffman Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1 J. Biol. Chem. 271 1996 17861 17868
8. H.G. Elmendorf, and K. Haldar Identification and localization of ERD2 in the malaria parasite Plasmodium falciparum: separation from sites of sphingomyelin synthesis and implications for organization of the Golgi EMBO J. 12 1993 4763 4773
9. D. Fernando, C. Rodrigo, and S. Rajapakse Primaquine in vivax malaria: an update and review on management issues Malar. J. 10 2011 351
10. M.R. Galinski, E.V. Meyer, and J.W. Barnwell Plasmodium vivax: modern strategies to study a persistent parasite's life cycle Adv. Parasitol. 81 2013 1 26
11. M. Grompe, S. Lindstedt, M. al-Dhalimy, N.G. Kennaway, J. Papaconstantinou, C.A. Torres-Ramos, C.N. Ou, and M. Finegold Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I Nat. Genet. 10 1995 453 460
12. C.A. Guerra, R.E. Howes, A.P. Patil, P.W. Gething, T.P. Van Boeckel, W.H. Temperley, C.W. Kabaria, A.J. Tatem, B.H. Manh, and I.R. Elyazar The international limits and population at risk of Plasmodium vivax transmission in 2009 PLoS Negl. Trop. Dis. 4 2010 e774
13. M.R. Hollingdale, W.E. Collins, C.C. Campbell, and A.L. Schwartz In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax Am. J. Trop. Med. Hyg. 34 1985 216 222
14. K. Kaiser, K. Matuschewski, N. Camargo, J. Ross, and S.H. Kappe Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins Mol. Microbiol. 51 2004 1221 1232
15. J. Kevin Baird Malaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life-averting the infectious bite preempts these hazards Pathog. Glob. Health 107 2013 475 479
16. W.A. Krotoski, R.S. Bray, P.C. Garnham, R.W. Gwadz, R. Killick-Kendrick, C.C. Draper, G.A. Targett, D.M. Krotoski, M.W. Guy, L.C. Koontz, and F.B. Cogswell Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36-to 40-hour pre-erythrocytic forms Am. J. Trop. Med. Hyg. 31 1982 211 225
17. W.A. Krotoski, W.E. Collins, R.S. Bray, P.C. Garnham, F.B. Cogswell, R.W. Gwadz, R. Killick-Kendrick, R. Wolf, R. Sinden, L.C. Koontz, and P.S. Stanfill Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection Am. J. Trop. Med. Hyg. 31 1982 1291 1293
18. W.A. Krotoski, P.C. Garnham, R.S. Bray, D.M. Krotoski, R. Killick-Kendrick, C.C. Draper, G.A. Targett, and M.W. Guy Observations on early and late post-sporozoite tissue stages in primate malaria. I. Discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection Am. J. Trop. Med. Hyg. 31 1982 24 35
19. D.C. Mackellar, M.T. O'Neill, A.S. Aly, J.B. Sacci Jr., A.F. Cowman, and S.H. Kappe Plasmodium falciparum PF10-0164 (ETRAMP10.3) is an essential parasitophorous vacuole and exported protein in blood stages Eukaryot. Cell 9 2010 784 794
20. S. March, S. Ng, S. Velmurugan, A. Galstian, J. Shan, D.J. Logan, A.E. Carpenter, D. Thomas, B.K. Sim, and M.M. Mota A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax Cell Host Microbe 14 2013 104 115
21. M.B. Markus Malaria: origin of the term "hypnozoite" J. Hist. Biol. 44 2011 781 786
22. D. Mazier, I. Landau, P. Druilhe, F. Miltgen, C. Guguen-Guillouzo, D. Baccam, J. Baxter, J.P. Chigot, and M. Gentilini Cultivation of the liver forms of Plasmodium vivax in human hepatocytes Nature 307 1984 367 369
23. J.L. Miller, A. Harupa, S.H. Kappe, and S.A. Mikolajczak Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development Infect. Immun. 80 2012 1399 1407
24. A.K. Mueller, N. Camargo, K. Kaiser, C. Andorfer, U. Frevert, K. Matuschewski, and S.H. Kappe Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface Proc. Natl. Acad. Sci. USA 102 2005 3022 3027
25. A.R. Noe, D.J. Fishkind, and J.H. Adams Spatial and temporal dynamics of the secretory pathway during differentiation of the Plasmodium yoelii schizont Mol. Biochem. Parasitol. 108 2000 169 185
26. Y. Pei, J.L. Miller, S.E. Lindner, A.M. Vaughan, M. Torii, and S.H. Kappe Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development Cell. Microbiol. 15 2013 1508 1526
27. R.N. Price, N.M. Douglas, and N.M. Anstey New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance Curr. Opin. Infect. Dis. 22 2009 430 435
28. J. Rodhain Paradoxical behaviour of Plasmodium vivax in the chimpanzee Trans. R. Soc. Trop. Med. Hyg. 50 1956 287 293
29. P. Rongnoparut, N. Supsamran, J. Sattabongkot, N. Suwanabun, and R. Rosenberg Phenotype and genotype diversity in the circumsporozoite proteins of Plasmodium vivax in Thailand Mol. Biochem. Parasitol. 74 1995 201 210
30. W. Roobsoong, S.P. Maher, N. Rachaphaew, S.J. Barnes, K.C. Williamson, J. Sattabongkot, and J.H. Adams A rapid sensitive, flow cytometry-based method for the detection of Plasmodium vivax-infected blood cells Malar. J. 13 2014 55
31. R. Rosenberg, R.A. Wirtz, D.E. Lanar, J. Sattabongkot, T. Hall, A.P. Waters, and C. Prasittisuk Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax Science 245 1989 973 976
32. J. Sattabongkot, N. Yimamnuaychoke, S. Leelaudomlipi, M. Rasameesoraj, R. Jenwithisuk, R.E. Coleman, R. Udomsangpetch, L. Cui, and T.G. Brewer Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax Am. J. Trop. Med. Hyg. 74 2006 708 715
33. H.E. Shortt, and P.C. Garnham Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses BMJ 1 1948 1225 1228
34. H.E. Shortt, and P.C. Garnham The pre-erythrocytic stage of human malaria, Plasmodium vivax BMJ 1 1948 547
35. O. Silvie, S. Briquet, K. Müller, G. Manzoni, and K. Matuschewski Post-transcriptional silencing of UIS4 in Plasmodium berghei sporozoites is important for host switch Mol. Microbiol. 91 2014 1200 1213
36. S. Uni, M. Aikawa, W.E. Collins, C.C. Campbell, and M.R. Hollingdale Electron microscopy of Plasmodium vivax exoerythrocytic schizonts grown in vitro in a hepatoma cell line Am. J. Trop. Med. Hyg. 34 1985 1017 1021
37. A.M. Vaughan, M.T. O'Neill, A.S. Tarun, N. Camargo, T.M. Phuong, A.S. Aly, A.F. Cowman, and S.H. Kappe Type II fatty acid synthesis is essential only for malaria parasite late liver stage development Cell. Microbiol. 11 2009 506 520
38. A.M. Vaughan, S.A. Mikolajczak, E.M. Wilson, M. Grompe, A. Kaushansky, N. Camargo, J. Bial, A. Ploss, and S.H. Kappe Complete Plasmodium falciparum liver-stage development in liver-chimeric mice J. Clin. Invest. 122 2012 3618 3628
39. A. Voorberg-van der Wel, A.M. Zeeman, S.M. van Amsterdam, A. van den Berg, E.J. Klooster, S. Iwanaga, C.J. Janse, G.J. van Gemert, R. Sauerwein, and N. Beenhakker Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms PLoS ONE 8 2013 e54888
40. N.J. White Determinants of relapse periodicity in Plasmodium vivax malaria Malar. J. 10 2011 297
41. N.J. White, and M. Imwong Relapse Adv. Parasitol. 80 2012 113 150